207 related articles for article (PubMed ID: 35590373)
1. Exploring the impact of the COVID-19 pandemic on syringe services programs in rural Kentucky.
Glick JL; Grieb SM; Harris SJ; Weir BW; Smith KC; Puryear T; Hamilton White R; Allen ST
Harm Reduct J; 2022 May; 19(1):47. PubMed ID: 35590373
[TBL] [Abstract][Full Text] [Related]
2. Law enforcement and syringe services program implementation in rural counties in Kentucky: a qualitative exploration.
Allen ST; Danforth S; Grieb SM; Glick JL; Harris SJ; Tomko C; Sherman SG
Harm Reduct J; 2022 Sep; 19(1):109. PubMed ID: 36180853
[TBL] [Abstract][Full Text] [Related]
3. Factors that influence enrollment in syringe services programs in rural areas: a qualitative study among program clients in Appalachian Kentucky.
Ibragimov U; Cooper KE; Batty E; Ballard AM; Fadanelli M; Gross SB; Klein EM; Lockard S; Young AM; Cooper HLF
Harm Reduct J; 2021 Jun; 18(1):68. PubMed ID: 34193165
[TBL] [Abstract][Full Text] [Related]
4. Applications of research evidence during processes to acquire approvals for syringe services program implementation in rural counties in Kentucky.
Allen ST; Grieb SM; Glick JL; White RH; Puryear T; Smith KC; Weir BW; Sherman SG
Ann Med; 2022 Dec; 54(1):404-412. PubMed ID: 35098828
[TBL] [Abstract][Full Text] [Related]
5. Motivation to Change and Treatment Participation Among Syringe Service Program Utilizers in Rural Kentucky.
Surratt HL; Otachi JK; Williams T; Gulley J; Lockard AS; Rains R
J Rural Health; 2020 Mar; 36(2):224-233. PubMed ID: 31415716
[TBL] [Abstract][Full Text] [Related]
6. Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs.
Allen ST; Grieb SM; O'Rourke A; Yoder R; Planchet E; White RH; Sherman SG
Harm Reduct J; 2019 May; 16(1):33. PubMed ID: 31109339
[TBL] [Abstract][Full Text] [Related]
7. A qualitative analysis of rural syringe service program fidelity in Appalachian Kentucky: Staff and participant perspectives.
Batty EJ; Ibragimov U; Fadanelli M; Gross S; Cooper K; Klein E; Ballard AM; Young AM; Lockard AS; Oser CB; Cooper HLF
J Rural Health; 2023 Mar; 39(2):328-337. PubMed ID: 36117151
[TBL] [Abstract][Full Text] [Related]
8. The effects of COVID-19 on New York State's Drug User Health Hubs and syringe service programs: a qualitative study.
Ude M; Behrends CN; Kelly S; Schackman BR; Clear A; Goldberg R; Gelberg K; Kapadia SN
Harm Reduct J; 2023 Feb; 20(1):12. PubMed ID: 36732773
[TBL] [Abstract][Full Text] [Related]
9. Pre-Exposure Prophylaxis Barriers, Facilitators and Unmet Need Among Rural People Who Inject Drugs: A Qualitative Examination of Syringe Service Program Client Perspectives.
Surratt HL; Yeager HJ; Adu A; González EA; Nelson EO; Walker T
Front Psychiatry; 2022; 13():905314. PubMed ID: 35706473
[TBL] [Abstract][Full Text] [Related]
10. Capacity for sustainment of recently established syringe service programs in Appalachian Kentucky: The central role of staff champions.
Cooper HLF; Gross S; Klein E; Fadanelli M; Ballard A; Lockard S; Batty E; Young A; Ibragimov U
Drug Alcohol Rev; 2022 May; 41(4):863-872. PubMed ID: 35112747
[TBL] [Abstract][Full Text] [Related]
11. Barriers to engaging people who use drugs in harm reduction services during the COVID-19 pandemic: A mixed methods study of syringe services program perspectives.
Austin EJ; Corcorran MA; Briggs ES; Frost MC; Behrends CN; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Jarlais DCD; Williams EC; Glick SN
Int J Drug Policy; 2022 Nov; 109():103825. PubMed ID: 35977459
[TBL] [Abstract][Full Text] [Related]
12. HCV serostatus and injection sharing practices among those who obtain syringes from pharmacies and directly and indirectly from syringe services programs in rural New England.
Romo E; Rudolph AE; Stopka TJ; Wang B; Jesdale BM; Friedmann PD
Addict Sci Clin Pract; 2023 Jan; 18(1):2. PubMed ID: 36597153
[TBL] [Abstract][Full Text] [Related]
13. Syringe Service Program Utilization, Barriers, and Preferences for Design in Rural Appalachia: Differences between Men and Women Who Inject Drugs.
Lancaster KE; Cooper HLF; Browning CR; Malvestutto CD; Bridges JFP; Young AM
Subst Use Misuse; 2020; 55(14):2268-2277. PubMed ID: 32748730
[No Abstract] [Full Text] [Related]
14. Implementation of Syringe Services Programs to Prevent Rapid Human Immunodeficiency Virus Transmission in Rural Counties in the United States: A Modeling Study.
Goedel WC; King MRF; Lurie MN; Galea S; Townsend JP; Galvani AP; Friedman SR; Marshall BDL
Clin Infect Dis; 2020 Mar; 70(6):1096-1102. PubMed ID: 31143944
[TBL] [Abstract][Full Text] [Related]
15. Factors Associated with Sterile Syringe Acquisition among People Who Inject Drugs in West Virginia.
Allen ST; Mazhnaya A; O'Rourke A; White RH; Wedlock P; Grieb SM; Kilkenny ME; Walls M; Sherman SG
Subst Use Misuse; 2021; 56(12):1776-1784. PubMed ID: 34311667
[TBL] [Abstract][Full Text] [Related]
16. The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in an rural American state.
Thakarar K; Kohut M; Hutchinson R; Bell R; Loeb HE; Burris D; Fairfield KM
Harm Reduct J; 2022 Jul; 19(1):80. PubMed ID: 35869523
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for loss to follow-up of persons who inject drugs enrolled at syringe services programs in Kentucky.
Soria J; Johnson T; Collins J; Corby-Lee G; Thacker J; White C; Hoven A; Thornton A
Int J Drug Policy; 2021 Sep; 95():103255. PubMed ID: 33853033
[TBL] [Abstract][Full Text] [Related]
18. "We were building the plane as we were flying it, and we somehow made it to the other end": syringe service program staff experiences and well-being during the COVID-19 pandemic.
Wang A; Jawa R; Mackin S; Whynott L; Buchholz C; Childs E; Bazzi AR
Harm Reduct J; 2022 Jul; 19(1):78. PubMed ID: 35841101
[TBL] [Abstract][Full Text] [Related]
19. Association of spatial proximity to fixed-site syringe services programs with HCV serostatus and injection equipment sharing practices among people who inject drugs in rural New England, United States.
Romo E; Stopka TJ; Jesdale BM; Wang B; Mazor KM; Friedmann PD
Harm Reduct J; 2024 Jan; 21(1):23. PubMed ID: 38282000
[TBL] [Abstract][Full Text] [Related]
20. Access to HIV, Viral Hepatitis, and Substance Use Disorder Treatment/Overdose Prevention Services: A Qualitative Analysis of Syringe Service Programs (SSPs) Serving Rural PWID.
Carnes NA; Asher AK; Bohm MK; Bessler PA
Subst Use Misuse; 2021; 56(13):1933-1940. PubMed ID: 34353216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
